US › Healthcare

EDAP TMS S.A. (FOCL)

US · Healthcare · Medical Distribution

$6.34+6.20%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

$17.9M

Revenue YoY

+25.3%

Net profit

$-9.1M

Profit YoY

-22.4%

EPS

$-0.24

EPS estimate

$-0.21

Net margin

-51.0%

EPS came in at -0.24 against a street estimate of -0.21 — a miss of 14.3%.

Key statistics

Market cap

$229.4M

Forward P/E

38.9

P/B

22.75

Book value

$0.27

EPS (TTM)

$-0.82

52-week high

$6.36

52-week low

$1.21

50-day MA

$5.11

200-day MA

$3.81

Beta

-0.03

Analyst view

with an average price target of $8.50.

Shareholding

Insiders

6.13%

Institutions

38.84%

Largest institutional holders

Fund	Stake
Soleus Capital Management, L.P.	19.50%
Morgan Stanley - Brokerage Accounts	8.93%
Rock Springs Capital Management LP	3.68%
FLAX POND CAPITAL, LLC	2.09%
Bruce & Co Inc	1.17%
UBS Group AG	0.45%
Parkman Healthcare Partners LLC	0.41%
OHE Financial Inc	0.36%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for EDAP TMS S.A. — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.